You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure INF-9:  Prevalence of HCV current infection and HCV genotypes among injecting drug users, where data available – Part (iii) Percentage distribution of HCV genotypes (G1 to G4) in samples of injecting drug users

Figure INF-09 part iii

inffig09c-en.swf

Notes:

See 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Mathei C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):514-22.

Data filter | inffig09c-en.xml